Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging results from its Phase 2 OT-007B clinical trial. The study evaluated Oticara’s proprietary nasal-mucosa-optimized steroid cream in patients suffering from persistent CRS symptoms after…
Alzheon, Inc., a clinical-stage biopharmaceutical company advancing novel therapies and diagnostics for Alzheimer’s disease (AD) and other neurodegenerative disorders, announced the peer-reviewed publication of its pivotal APOLLOE4 Phase 3 trial results in Drugs, a leading scientific journal. The paper, titled…
Wiley, a global leader in research intelligence and academic publishing, has launched Wiley AI Gateway, an innovative AI-native research intelligence platform designed to connect researchers, publishers, and AI systems through a single, trusted access point. This marks a major milestone…
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced the appointment of Giovanni Galliano as General Manager for Italy. This appointment marks Avanzanite’s seventh executive leadership hire in 2025, reinforcing its vision…
The Estée Lauder Companies Inc., under the High Patronage of Mr. Emmanuel Macron, President of the French Republic, has officially opened its Fragrance Atelier within La Maison des Parfums on Rue Volney in Paris. This state-of-the-art facility represents a major…
Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging Phase 2 clinical trial results for its proprietary nasal-mucosa-optimized steroid cream, OT-007B. The therapy demonstrated rapid, durable, and clinically meaningful improvements in patients with…
eClinical Solutions LLC, a global leader in digital clinical software and data management services, announced two significant achievements underscoring its commitment to advancing data science innovation. At the 2025 Society for Clinical Data Management (SCDM) Annual Conference, the company’s elluminate…
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small molecule therapies that target STAT3 for the treatment of fibrosis-driven diseases, announced an update on preliminary results from its Phase 2 REVERT clinical trial of TTI-101 in patients with…
Enpro Inc., a leading industrial technology company, has announced definitive agreements to acquire two strategically aligned companies — AlpHa Measurement Solutions and Overlook Industries — for a combined total of approximately $280 million in cash. These acquisitions mark a significant…
A team of scientists at Children’s Hospital Los Angeles (CHLA) has made a major breakthrough in understanding Ewing Sarcoma, a rare and aggressive cancer of the bone and soft tissue that predominantly strikes children and adolescents. Their findings provide compelling…